Quality of life after whole pelvic versus prostate-only external beam radiotherapy for prostate cancer: A matched-pair comparison

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 1, 2011, Pages 23-28

  Pinkawa, Michael ^a   Piroth, Marc D ^a   Holy, Richard ^a   Fischedick, Karin ^a   Klotz, Jens ^a   Székely Orbán, Dalma ^a   Eble, Michael J ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Prostate cancer; Quality of life; Radiotherapy; Toxicity; Whole pelvic radiotherapy

Indexed keywords

AFTER-TREATMENT; DOSE LEVELS; EXPANDED PROSTATE CANCER INDEX COMPOSITES; EXTERNAL BEAM RADIOTHERAPY; HEALTH-RELATED QUALITY OF LIVES; HIGH DOSE LEVELS; PELVIC NODES; PLANNING TARGET VOLUMES; PROSTATE CANCERS; QUALITY OF LIFE; RISK FACTORS; TYPICAL DAY; WHOLE PELVIC RADIOTHERAPY;

DISEASES; HEALTH RISKS; SURVEYS; TOXICITY;

RADIOTHERAPY;

ANTIANDROGEN;

ADULT; AGED; ARTICLE; BLADDER FUNCTION; CLINICAL TRIAL; CONTROLLED STUDY; DEFECATION URGENCY; EXTERNAL BEAM RADIOTHERAPY; HEMATOCHEZIA; HUMAN; INTERMETHOD COMPARISON; INTESTINE FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATE ONLY RADIOTHERAPY; QUALITY OF LIFE; QUESTIONNAIRE; SEXUAL FUNCTION; WHOLE PELVIS RADIOTHERAPY;

AGED; AGED, 80 AND OVER; HEALTH STATUS; HUMANS; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; ORGAN SIZE; PELVIS; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; RADIOTHERAPY DOSAGE; RECTUM; SEXUAL BEHAVIOR; URINARY BLADDER;

EID: 79961129594     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.05.054     Document Type: Article

References (25)

1. G.K. Zagars, A. Pollack, and A.C. Eschenbach Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer Urology 58 2001 233 239 (Pubitemid 32728063)
2. C.A. Lawton, K. Winter, and D. Grignon Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: Updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31 J Clin Oncol 23 2005 800 807 (Pubitemid 46224179)
3. C.A. Lawton, M. DeSilvio, and M. Roach III An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: Updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions Int J Radiat Oncol Biol Phys 69 2007 646 655 (Pubitemid 47418390)
4. S. Abuzallouf, I. Dayes, and H. Lukka Baseline staging of newly diagnosed prostate cancer: A summary of the literature J Urol 171 2004 2122 2127 (Pubitemid 38625418)
5. N. Takahashi, T. Inoue, and J. Lee The roles of PET and PET/CT in the diagnosis and management of prostate cancer Oncology 72 2007 226 233 (Pubitemid 351161615)
6. M. Roach III, C. Marquez, and H.S. Yuo Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer Int J Radiat Oncol Biol Phys 28 1994 33 37 (Pubitemid 24012852)
7. A. Heidenreich, C.H. Ohlmann, and S. Polyakov Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy Eur Urol 52 2007 29 37 (Pubitemid 46803038)
8. P. Pommier, S. Chabaud, and J.L. Lagrange Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01 J Clin Oncol 25 2007 5366 5373 (Pubitemid 350232211)
9. M. Roach III, M. DeSilvio, and R. Valicenti Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial Int J Radiat Oncol Biol Phys 66 2006 647 653 (Pubitemid 44436716)
10. N. Bittner, G.S. Merrick, and K. Wallner Whole-pelvis radiotherapy in combination with interstitial brachytherapy: Does coverage of the pelvic lymph nodes improve treatment outcome in high-risk prostate cancer? Int J Radiat Oncol Biol Phys 76 2010 1078 1084
11. C. Vargas, J. Demanes, and T.P. Boike Matched-pair analysis of prostate cancer patients\ with a high risk of positive lymph nodes treated with and without pelvic RT and high-dose radiation using high dose rate brachytherapy Am J Clin Oncol 29 2006 451 457 (Pubitemid 44536025)
12. A.A. Aizer, J.B. Yu, and A.M. McKeon Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinoma Int J Radiat Oncol Biol Phys 75 2009 1344 1349
13. G. Goldner, N. Wachter-Gerstner, and S. Wachter Acute side effects during 3-D-planned conformal radiotherapy of prostate cancer: Differences between patient's self-reported questionnaire and the corresponding doctor's report Strahlenther Onkol 179 2003 320 327 (Pubitemid 36606023)
14. International Commission on Radiation Units and Measurements ICRU Report 50: Prescribing, recording and reporting photon beam therapy 1993 ICRU Bethesda, MD
15. M. Pinkawa, M.D. Piroth, and K. Fischedick Impact of the target volume (prostate alone vs. prostate with seminal vesicles) and fraction dose (1.8 Gy vs. 2.0 Gy) on quality of life changes after external-beam radiotherapy for prostate cancer Strahlenther Onkol 185 2009 724 730
16. J.T. Wei, R.L. Dunn, and M.S. Litwin Development and validation of the expanded prostate cancer index composite (epic) for comprehensive assessment of health-related quality of life in men with prostate cancer Urology 56 2000 899 905
17. E. Volz-Sidiropoulou, M. Pinkawa, and K. Fischedick Factor analysis of the Expanded Prostate Cancer Index Composite (EPIC) in a patient group after primary (external beam radiotherapy and permanent iodine-125 brachytherapy) and postoperative radiotherapy for prostate cancer Curr Urol 2 2008 122 129
18. M. Pinkawa, M.D. Piroth, and K. Fischedick Self-assessed bowel toxicity after external beam radiotherapy for prostate cancer: Predictive factors on irritative symptoms, incontinence and rectal bleeding Radiat Oncol 4 2009 36
19. M. Pinkawa, M.D. Piroth, and B. Asadpour Neoadjuvant hormonal therapy and external\ beam radiotherapy versus external-beam irradiation alone for prostate cancer: A quality-of life analysis Strahlenther Onkol 185 2009 101 108
20. M. Bolla, L. Collette, and L. Blank Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomised trial Lancet 360 2002 103 108 (Pubitemid 34786197)
21. T.M. Muanza, P.S. Albert, and S. Smith Comparing measures of acute bowel toxicity in patients with prostate cancer treated with external beam radiation therapy Int J Radiat Oncol Biol Phys 62 2005 1316 1321 (Pubitemid 40982049)
22. D. Osoba, G. Rodrigues, and J. Myles Interpreting the significance of changes in health related quality-of-life scores J Clin Oncol 16 1998 139 144 (Pubitemid 28041591)
23. M. Pinkawa, K. Fischedick, and B. Asadpour Low-grade toxicity after conformal radiation therapy for prostate cancer: Impact of bladder volume Int J Radiat Oncol Biol Phys 64 2006 835 841 (Pubitemid 43183582)
24. M. Pinkawa, K. Fischedick, and B. Asadpour Toxicity profile with a large prostate volume after external beam radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 70 2008 83 89 (Pubitemid 350251028)
25. J.B. Ashman, M.J. Zelefsky, and M.S. Hunt Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy Int J Radiat Oncol Biol Phys 63 2005 765 771 (Pubitemid 41400064)